BLRX - BioLine Rx Ltd

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development11,17711,48911,866
Selling General and Administrative5,3364,7075,389
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-16,513-16,196-17,255
Income from Continuing Operations
Total Other Income/Expenses Net6941,9026,627
Earnings Before Interest and Taxes-15,819-14,294-10,628
Interest Expense22106448
Income Before Tax-15,841-14,400-11,076
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-15,841-14,400-11,076
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-15,841-14,400-11,076
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-15,841-14,400-11,076